This solicitation closed on May 29, 2026

View current DEFENSE HEALTH AGENCY (DHA) opportunities →
ClosedRFI

Chemoinformatic Platform

DEFENSE HEALTH AGENCY (DHA)DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY

AI Overview

Market research for web-based chemoinformatic platform software supporting drug development, chemical reactions, drug metabolism research, and IP prior art analysis at USAMRIID.

This summary is AI-generated from the official solicitation.

Key Details

Agency
DEFENSE HEALTH AGENCY (DHA)
Funding Amount
Release Date
May 15, 2026
Due Date
May 29, 2026 (Closed)

Official Description

Request for Information (RFI)/Sources Sought (SS) Notice Requiring Activity Name: The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Subject: This is a non-personal service(s) contract to contract mechanisms to supply a web-based chemoinformatic platform software license. This chemoinformatic platform is required to conduct state-of-the-art chemical research including drug development, chemical reactions, drug metabolism, and knowledge of prior art for intellectual proper...

View on official source

Change History

Opportunity AddedMay 15, 2026 at 9:26 PM

Chemoinformatic Platform

New SAM.gov opportunity: Chemoinformatic Platform

Similar Opportunities

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial